Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Clinical Efficacy and Safety of Nivolumab: Results of a <u>M</u> ulticenter, Op <u>e</u> n-label, Single-a <u>r</u> m, Japanese Phase II study in Mal <u>i</u> gnant Pleural Meso <u>t</u> helioma (MERIT)

PaperCitations, authors & open-access status

Clinical Efficacy and Safety of Nivolumab: Results of a <u>M</u> ulticenter, Op <u>e</u> n-label, Single-a <u>r</u> m, Japanese Phase II study in Mal <u>i</u> gnant Pleural Meso <u>t</u> helioma (MERIT) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 237 citations, 2019 year and closed oa status.

237
Citations
2019
Year
closed
OA Status

Related on ScholarIQ

Nobukazu Fujimoto
Author
Clinical Cancer Research
Journal
Occupational and environmental lung diseases
Topic
Occupational and environmental lung diseases
Topic
Cancer Immunotherapy and Biomarkers
Topic
Pleural and Pulmonary Diseases
Topic
470M+ articles · free account